AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BCAL DIAGNOSTICS LTD

0.090

-0.004-4.26%

Volume:33.30K

Turnover:3K

Market Cap:33.13M

PE:-4.49

High:0.090

Open:0.090

Low:0.090

Close:0.094

52wk High:0.155

52wk Low:0.052

Shares:368.07M

Float Shares:202.44M

Volume Ratio:0.10

T/O Rate:0.02%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.020

EPS(LYR):-0.020

ROE:-273.29%

ROA:-50.29%

PB:-40.09

PE(LYR):-4.50

Loading ...

Overview Company News Filings

Becton, Dickinson's Fiscal Q3 Results Show Progress Amid Major Headwinds, RBC Says

MT Newswires Live

Becton, Dickinson Fiscal Q3 Adjusted Earnings, Revenue Rise; Lifts 2026 Adjusted EPS Guidance

MT Newswires Live

GUIDANCE: (BDX) Becton Dickinson Expects Fiscal 2026 Adjusted EPS Range $12.62 to $12.72,vs. FactSet Est of $12.61

MT Newswires Live

UBS Initiates Coverage on Becton, Dickinson and Company With Buy Rating, $190 Price Target

MT Newswires Live

3 Dividend Aristocrats Still Worth Watching As Rates Stay Higher For Longer

Simply Wall St.

Goldman Sachs Adjusts Price Target on Becton, Dickinson and Company to $152 From $150, Maintains Neutral Rating

MT Newswires Live

Waters Seen Benefiting From BD Turnaround, Pharma Manufacturing Tailwinds, RBC Says

MT Newswires Live

BCAL to Acquire Shares in Genetic Signatures

Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $180 From $190

MT Newswires Live

BCAL to Acquire Shares in Genetic Signatures

BCAL Diagnostics Ltd - to Buy 10.2% Stake in Genetic Signatures for A$1.39 Mln

THOMSON REUTERS

Bcal Diagnostics Secures A$4.9 Million Under Convertible Note Facility

BCAL Diagnostics - Secures A$4.9 Mln Under Convertible Note Facility

THOMSON REUTERS

BCAL Diagnostics - Expects Remaining FY26 R&D Tax Offset in October 2026

THOMSON REUTERS

Is Vizient’s Nod to BD CentroVena One Quietly Reframing Becton Dickinson’s (BDX) Competitive Moat?

Simply Wall St.

Becton, Dickinson Secures Vizient Recognition for CentroVena One Insertion System

MT Newswires Live

Becton Dickinson (BDX) Stock Could Be 20.6% Undervalued After Class I Spinal Tray Recalls

Simply Wall St.

BUZZ-Australia's BCAL Diagnostics soars on development of new blood test for breast cancer

BofA Adjusts Price Target on Becton, Dickinson and Company to $170 From $177

MT Newswires Live

A Look At Becton Dickinson (BDX) Valuation After The Elyra Kidney Stone Care Launch

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/BDX.AU/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BDX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BDX.AU\",,,,,undefined,":{"symbol":"BDX.AU","market":"AU","secType":"STK","nameCN":"BCAL DIAGNOSTICS LTD","latestPrice":0.09,"timestamp":1791436320000,"preClose":0.094,"halted":0,"volume":33298,"delay":0,"changeRate":-0.04255319148936174,"nameEN":"BCAL DIAGNOSTICS LTD","floatShares":202437334,"shares":368067640,"eps":-0.020055,"marketStatus":"Closed","change":-0.004,"latestTime":"10-08 16:12:00 AEDT","open":0.09,"high":0.09,"low":0.09,"amount":2997,"amplitude":0,"askPrice":0.092,"askSize":44000,"bidPrice":0.09,"bidSize":22702,"shortable":3,"etf":0,"ttmEps":-0.020055,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791500400000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.094,"openAndCloseTimeList":[[1791414000000,1791435600000]],"volumeRatio":0.098981,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"BDX.AU","preClose":0.093,"auctionPrice":0.094,"auctionVolume":118,"auction":3,"marketStatus":"盘后竞价","timestamp":1791349200691}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BDX.AU\",,,,,undefined,":{"symbol":"BDX.AU","floatShares":202437334,"roa":"-50.29%","roe":"-273.29%","lyrEps":-0.02,"volumeRatio":0.098981,"shares":368067640,"dividePrice":0,"high":0.09,"amplitude":0,"preClose":0.094,"low":0.09,"week52Low":0.052,"pbRate":"-40.09","psRate":"14.08","week52High":0.155,"institutionHeld":0,"latestPrice":0.09,"committee":-0.319301,"eps":-0.020055,"divideRate":0,"volume":33298,"delay":0,"ttmEps":-0.020055,"open":0.09,"prevYearClose":0.105,"prevWeekClose":0.087,"prevMonthClose":0.09,"prevQuarterClose":0.09,"fiveDayClose":0.09,"twentyDayClose":0.076,"sixtyDayClose":0.076},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BDX.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-03","symbol":"BDX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788393600000,"name":null,"time":"","dateTimestamp":1788357600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BDX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BDX.AU\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657647934","title":"Becton, Dickinson's Fiscal Q3 Results Show Progress Amid Major Headwinds, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2657647934","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657647934?lang=en_us&edition=fundamental","pubTime":"2026-08-07 23:44","pubTimestamp":1786117445,"startTime":"0","endTime":"0","summary":"Becton, Dickinson's  fiscal Q3 results delivered another beat and raise and showed the company returning to middle single digit topline growth, RBC Capital Markets said in a note emailed Friday.However, the company's \"growth recovery back to consistent middle single digit growth is yet to be proven out,\" even though the beat was a \"positive indicator of improving business performance,\" the note said.Factors like Alaris, China, and vaccine headwinds will likely weigh on the company's 2027 performance, RBC said.The investment firm noted that the company's management raised the 2026 organic growth outlook to the high end of low single digit from just low single digit previously, and also raised the EPS mid-point guidance.For 2027, however, the framework remains low single digit revenue growth due to a 200 basis-point Alaris remediation headwind and China likely decreasing to 3% to 4% of revenue, the note said.RBC kept the company's sector perform rating and lifted its price target to $180","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0433182093.SGD","LU2065732104.USD","LU0130103400.USD","LU0289961442.SGD","LU1489326972.SGD","BK4585","BDX","LU1894683348.USD","LU0878866978.SGD","BDX.AU","LU1150488218.USD","LU1894683264.USD","BK7067","LU0289739343.SGD","LU0477156797.USD","BK4504","LU0985489474.SGD","LU0985320562.USD","PRGS","BK4588","LU1571399168.USD","BK4082","LU0266013472.USD","LU1150488135.SGD","IE00BFXG1179.USD","LU0130518102.USD","LU0162691827.USD","LU0511384066.AUD","LU0648000940.SGD","LU1201861165.SGD","BK4097","LU1059921491.USD","LU0068578508.USD","LU0006061336.USD","LU1854104046.USD","IHI","LU0072461881.USD","LU1854103824.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657638444","title":"Becton, Dickinson Fiscal Q3 Adjusted Earnings, Revenue Rise; Lifts 2026 Adjusted EPS Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2657638444","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657638444?lang=en_us&edition=fundamental","pubTime":"2026-08-06 19:08","pubTimestamp":1786014492,"startTime":"0","endTime":"0","summary":"Becton, Dickinson  reported fiscal Q3 adjusted earnings from continuing operations Thursday of $3.23 per diluted share, up from $3.08 a year earlier.Analysts polled by FactSet expected $3.14.Revenue for the quarter ended June 30 was $4.98 billion, compared with $4.73 billion a year earlier.Analysts expected $4.89 billion.For fiscal 2026, the company said it now expects adjusted earnings of $12.62 to $12.72 per diluted share, from its prior guidance of $12.52 to $12.72. Analysts are looking for $12.61.The company maintained its low single-digit plus revenue growth outlook.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BFXG1179.USD","LU1894683264.USD","LU1150488135.SGD","IHI","BK4588","LU0985489474.SGD","LU1489326972.SGD","LU1150488218.USD","BK4504","LU0130103400.USD","LU0162691827.USD","LU0072461881.USD","LU1059921491.USD","LU1201861165.SGD","LU1894683348.USD","LU0289961442.SGD","LU0130518102.USD","LU0433182093.SGD","BK7067","LU0289739343.SGD","LU1854104046.USD","LU0878866978.SGD","LU0477156797.USD","LU1854103824.USD","LU0266013472.USD","LU0985320562.USD","BK4082","BDX.AU","LU0006061336.USD","LU0068578508.USD","LU1571399168.USD","LU0648000940.SGD","BK4585","LU0511384066.AUD","BDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657873676","title":"GUIDANCE: (BDX) Becton Dickinson Expects Fiscal 2026 Adjusted EPS Range $12.62 to $12.72,vs. FactSet Est of $12.61","url":"https://stock-news.laohu8.com/highlight/detail?id=2657873676","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657873676?lang=en_us&edition=fundamental","pubTime":"2026-08-06 18:33","pubTimestamp":1786012400,"startTime":"0","endTime":"0","summary":"GUIDANCE: (BDX) Becton Dickinson Expects Fiscal 2026 Adjusted EPS Range $12.62 to $12.72,vs. FactSet Est of $12.61","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BDX","BDX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654883600","title":"UBS Initiates Coverage on Becton, Dickinson and Company With Buy Rating, $190 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2654883600","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654883600?lang=en_us&edition=fundamental","pubTime":"2026-07-28 22:37","pubTimestamp":1785249441,"startTime":"0","endTime":"0","summary":"Becton, Dickinson and Company (BDX) has an average rating of overweight and mean price target of $176.30, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic re","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1059921491.USD","LU0130103400.USD","LU0068578508.USD","LU0648000940.SGD","IHI","LU0985320562.USD","LU0985489474.SGD","LU1489326972.SGD","LU0162691827.USD","BK4588","LU1894683348.USD","LU1894683264.USD","LU0130518102.USD","LU0433182093.SGD","LU1150488218.USD","LU1571399168.USD","LU0289961442.SGD","BK4585","LU0511384066.AUD","LU0289739343.SGD","LU1854104046.USD","LU0072461881.USD","BDX","BDX.AU","BK7067","LU0266013472.USD","LU1150488135.SGD","IE00BFXG1179.USD","LU0006061336.USD","LU0878866978.SGD","LU1201861165.SGD","LU0477156797.USD","BK4504","LU1854103824.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651046482","title":"3 Dividend Aristocrats Still Worth Watching As Rates Stay Higher For Longer","url":"https://stock-news.laohu8.com/highlight/detail?id=2651046482","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651046482?lang=en_us&edition=fundamental","pubTime":"2026-07-15 06:25","pubTimestamp":1784067949,"startTime":"0","endTime":"0","summary":"With Fed Chair Kevin Warsh signaling that interest rates may stay higher for longer, inflation still above the 2% target, and oil prices jumping after renewed tensions in the Strait of Hormuz, many investors are reassessing how reliable their income stocks really are. Dividend Aristocrats, with long records of raising payouts and a focus on financial discipline, can look appealing when volatility and inflation risks rise together. This article walks through 3 stocks from our Dividend...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/3-dividend-aristocrats-still-worth-watching-as-rates-stay-hi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/3-dividend-aristocrats-still-worth-watching-as-rates-stay-hi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["STE","IE00B19Z3581.USD","LU0069063385.USD","LU1892829315.USD","LU0433182093.SGD","CLIX","LU0130103400.USD","LU0289961442.SGD","LU1489326972.SGD","BK4585","LU0689626769.HKD","LU0058720904.USD","BDX","CI","LU1894683348.USD","LU0878866978.SGD","LU0057025933.USD","LU0472753341.HKD","BDX.AU","LU1150488218.USD","LU1894683264.USD","BK7067","LU1261432733.SGD","LU0289739343.SGD","LU0477156797.USD","LU0985489474.SGD","IE00B19Z3B42.SGD","LU0985320562.USD","IE00BSNM7G36.USD","BK4588","LU1571399168.USD","EQRR","LU0266013472.USD","LU0868494617.USD","LU0130518102.USD","LU1150488135.SGD","LU0162691827.USD","LU0511384066.AUD","LU0648000940.SGD","CGDV","BK4196","LU0068578508.USD","LU0006061336.USD","LU0289739699.SGD","LU1854104046.USD","VIG","IHI","LU0072461881.USD","LU0124676726.USD","LU1854103824.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651170093","title":"Goldman Sachs Adjusts Price Target on Becton, Dickinson and Company to $152 From $150, Maintains Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2651170093","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651170093?lang=en_us&edition=fundamental","pubTime":"2026-07-14 19:31","pubTimestamp":1784028710,"startTime":"0","endTime":"0","summary":"Becton, Dickinson and Company (BDX) has an average rating of overweight and mean price target of $172.73, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic re","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0433182093.SGD","LU0511384066.AUD","LU0162691827.USD","BDX.AU","LU1571399168.USD","LU1201861165.SGD","BDX","IE00BFXG1179.USD","LU0068578508.USD","LU0985489474.SGD","LU1894683348.USD","LU0289739343.SGD","IHI","LU0878866978.SGD","BK4585","BK4588","BK4504","LU0072461881.USD","BK7067","LU0266013472.USD","LU0477156797.USD","LU1854103824.USD","LU1854104046.USD","LU1489326972.SGD","LU0289961442.SGD","LU0130518102.USD","LU0648000940.SGD","LU1894683264.USD","LU0006061336.USD","LU0985320562.USD","LU1150488135.SGD","LU1059921491.USD","LU0130103400.USD","BK4082","LU1150488218.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650292125","title":"Waters Seen Benefiting From BD Turnaround, Pharma Manufacturing Tailwinds, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2650292125","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650292125?lang=en_us&edition=fundamental","pubTime":"2026-07-09 20:23","pubTimestamp":1783599816,"startTime":"0","endTime":"0","summary":"Waters  could unlock stronger growth by turning around the recent acquired Becton Dickinson  biosciences and diagnostics businesses while benefiting from resilient demand tied to drug manufacturing, RBC Capital said in a Thursday note.Analysts said the acquired assets were under-managed rather than structurally weak and sees Waters' management applying its turnaround expertise to revive growth.RBC also expects the company to benefit from industry consolidation opportunities and its roughly 15% exposure to pharmaceutical manufacturing, which could gain from US re-shoring trends.RBC initiated coverage with an outperform rating and a $435 price target.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4504","LU2404859741.USD","LU1150488135.SGD","LU0985489474.SGD","LU0985320562.USD","BK7067","LU0511384066.AUD","LU1854103824.USD","BDX.AU","LU0130518102.USD","BK7118","LU1489326972.SGD","BK4585","LU0130103400.USD","LU0289961442.SGD","LU0289739343.SGD","LU0006061336.USD","GB00B4QBRK32.GBP","IE00BFXG1179.USD","GB00B4LPDJ14.GBP","LU0648000940.SGD","LU1894683348.USD","LU0433182093.SGD","LU0068578508.USD","LU1150488218.USD","LU0690374615.EUR","LU1721428933.USD","LU1894683264.USD","WAT.AU","BK4082","BK4121","LU0878866978.SGD","LU1854104046.USD","IHI","BK4588","LU0072461881.USD","LU2413666699.HKD","WAT","LU0347712357.USD","LU0162691827.USD","LU1059921491.USD","LU2404859667.USD","BD","LU1201861165.SGD","LU0477156797.USD","LU2413666426.HKD","LU0690374961.EUR","LU0266013472.USD","BDX","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649446988","title":"BCAL to Acquire Shares in Genetic Signatures","url":"https://stock-news.laohu8.com/highlight/detail?id=2649446988","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649446988?lang=en_us&edition=fundamental","pubTime":"2026-07-07 16:38","pubTimestamp":1783413518,"startTime":"0","endTime":"0","summary":"July 2 (Reuters) - BCAL Diagnostics Ltd::*BCAL TO ACQUIRE SHARES IN GENETIC SIGNATURES,GSS*TO BUY 10.2% STAKE IN GENETIC SIGNATURES FOR A$1.39 MILLION*Further company coverage: BDX.AX* ((Reuters.Brief","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nRSDXrYJs:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDX.AU","GSS.AU","BK7048","BK7067","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649624217","title":"Evercore ISI Adjusts Price Target on Becton, Dickinson and Company to $180 From $190","url":"https://stock-news.laohu8.com/highlight/detail?id=2649624217","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649624217?lang=en_us&edition=fundamental","pubTime":"2026-07-06 21:21","pubTimestamp":1783344069,"startTime":"0","endTime":"0","summary":"Becton, Dickinson and Company (BDX) has an average rating of overweight and mean price target of $172.55, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic re","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1854104046.USD","IE00BFXG1179.USD","IHI","BDX.AU","LU0648000940.SGD","LU0068578508.USD","BK4504","LU0289739343.SGD","LU1201861165.SGD","LU0130103400.USD","LU1854103824.USD","BK4082","LU0289961442.SGD","LU0878866978.SGD","LU1571399168.USD","LU0006061336.USD","LU1489326972.SGD","LU0511384066.AUD","LU0072461881.USD","LU0433182093.SGD","LU1150488135.SGD","LU0985489474.SGD","BDX","LU0477156797.USD","BK4588","LU1894683264.USD","LU0266013472.USD","LU0985320562.USD","BK7067","LU1059921491.USD","LU0162691827.USD","LU0130518102.USD","BK4585","LU1150488218.USD","LU1894683348.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648578901","title":"BCAL to Acquire Shares in Genetic Signatures","url":"https://stock-news.laohu8.com/highlight/detail?id=2648578901","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648578901?lang=en_us&edition=fundamental","pubTime":"2026-07-02 09:34","pubTimestamp":1782956083,"startTime":"0","endTime":"0","summary":"BRIEF-BCAL To Acquire Shares In Genetic SignaturesJuly 2 (Reuters)-BCAL Diagnostics LtdBDX.AX:BCAL TO ACQUIRE SHARES IN GENETIC SIGNATURES,GSSTO BUY 10.2% STAKE IN GENETIC SIGNATURES FOR A$1.39 MILLIONFurther company coverage:BDX.AX","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nTUE20NLFQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GSS.AU","BK7501","BK7067","BDX.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648852202","title":"BCAL Diagnostics Ltd - to Buy 10.2% Stake in Genetic Signatures for A$1.39 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2648852202","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648852202?lang=en_us&edition=fundamental","pubTime":"2026-07-02 08:04","pubTimestamp":1782950657,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nTUE20NLFQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BDX.AU","BK7048","GSS.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647449663","title":"Bcal Diagnostics Secures A$4.9 Million Under Convertible Note Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2647449663","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647449663?lang=en_us&edition=fundamental","pubTime":"2026-06-29 09:27","pubTimestamp":1782696449,"startTime":"0","endTime":"0","summary":"BRIEF-Bcal Diagnostics Secures A$4.9 Million Under Convertible Note FacilityJune 29 (Reuters)-BCAL Diagnostics LtdBDX.AX:SECURES A$4.9 MILLION UNDER CONVERTIBLE NOTE FACILITYEXPECTS REMAINING FY26 RD TAX OFFSET IN OCTOBER 2026Further company coverage:BDX.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nFWN42Y123:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647334978","title":"BCAL Diagnostics - Secures A$4.9 Mln Under Convertible Note Facility","url":"https://stock-news.laohu8.com/highlight/detail?id=2647334978","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647334978?lang=en_us&edition=fundamental","pubTime":"2026-06-29 07:57","pubTimestamp":1782691058,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260628:nFWN42Y123:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BDX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647234978","title":"BCAL Diagnostics - Expects Remaining FY26 R&D Tax Offset in October 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2647234978","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647234978?lang=en_us&edition=fundamental","pubTime":"2026-06-29 07:57","pubTimestamp":1782691058,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260628:nFWN42Y123:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BDX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647766349","title":"Is Vizient’s Nod to BD CentroVena One Quietly Reframing Becton Dickinson’s (BDX) Competitive Moat?","url":"https://stock-news.laohu8.com/highlight/detail?id=2647766349","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647766349?lang=en_us&edition=fundamental","pubTime":"2026-06-29 06:14","pubTimestamp":1782684892,"startTime":"0","endTime":"0","summary":"Earlier this month, Becton, Dickinson and Company announced that its BD CentroVena One Insertion System received an Innovative Technology contract from Vizient, recognizing the all-in-one central venous catheter insertion system for its potential to simplify central line placement and enhance patient and clinician safety.\nThis endorsement from Vizient’s expert hospital councils highlights CentroVena One’s differentiated workflow and safety advantages, which could influence purchasing...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/is-vizients-nod-to-bd-centrovena-one-quietly-reframing-becto","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/is-vizients-nod-to-bd-centrovena-one-quietly-reframing-becto","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0878866978.SGD","LU1571399168.USD","BK4585","LU0068578508.USD","LU1489326972.SGD","LU0289739343.SGD","LU0162691827.USD","LU0433182093.SGD","BD","BDX","LU1150488135.SGD","LU0648000940.SGD","LU0477156797.USD","LU0289961442.SGD","BK7067","LU0985489474.SGD","LU1150488218.USD","LU1854103824.USD","LU1854104046.USD","LU0266013472.USD","LU0511384066.AUD","LU1201861165.SGD","LU0130518102.USD","LU0006061336.USD","LU1059921491.USD","LU0130103400.USD","LU0072461881.USD","LU1894683264.USD","BK4588","BK4504","LU1894683348.USD","IE00BFXG1179.USD","BDX.AU","LU0985320562.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645833309","title":"Becton, Dickinson Secures Vizient Recognition for CentroVena One Insertion System","url":"https://stock-news.laohu8.com/highlight/detail?id=2645833309","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645833309?lang=en_us&edition=fundamental","pubTime":"2026-06-23 19:15","pubTimestamp":1782213326,"startTime":"0","endTime":"0","summary":"Becton, Dickinson  said Tuesday that Vizient granted an Innovative Technology contract to its BD CentroVena One central venous catheter insertion system.The medical technology company said the contract, awarded after an evaluation by hospital experts on Vizient's client-led councils, recognizes products with the potential to enhance healthcare delivery.The integrated device simplifies the procedure by combining the guidewire, needle, syringe, and catheter, resulting in 30% fewer steps and up to a 50% shorter procedure time, the company added.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1201861165.SGD","LU1150488135.SGD","LU0289739343.SGD","BK4504","LU0648000940.SGD","LU1489326972.SGD","LU1854104046.USD","LU0878866978.SGD","LU0130518102.USD","LU0477156797.USD","LU0985320562.USD","LU0130103400.USD","LU0266013472.USD","LU0006061336.USD","BDX","BK4588","LU1571399168.USD","BK7067","BDX.AU","LU0511384066.AUD","LU0289961442.SGD","LU1150488218.USD","LU0162691827.USD","LU0433182093.SGD","IE00BFXG1179.USD","LU0985489474.SGD","LU0068578508.USD","LU1894683348.USD","BK4585","LU0072461881.USD","BK4082","LU1894683264.USD","LU1059921491.USD","LU1854103824.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644418065","title":"Becton Dickinson (BDX) Stock Could Be 20.6% Undervalued After Class I Spinal Tray Recalls","url":"https://stock-news.laohu8.com/highlight/detail?id=2644418065","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644418065?lang=en_us&edition=fundamental","pubTime":"2026-06-20 02:49","pubTimestamp":1781894967,"startTime":"0","endTime":"0","summary":"Becton Dickinson (BDX) has initiated several voluntary Class I sub-recalls of BD Spinal Tray products across the US after FDA inspections flagged acceptance testing deficiencies at a supplier of bupivacaine in dextrose.\nSee our latest analysis for Becton Dickinson.\nBecton Dickinson's share price has been under pressure, with the stock down 26.14% on a year to date share price return and 6.59% over 90 days, even though the 1 year total shareholder return is 11.34%. This suggests momentum has...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/becton-dickinson-bdx-stock-could-be-206-undervalued-after-cl","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/becton-dickinson-bdx-stock-could-be-206-undervalued-after-cl","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0068578508.USD","LU1854104046.USD","LU1894683264.USD","LU0477156797.USD","BDX.AU","LU1854103824.USD","LU0985320562.USD","LU0130103400.USD","LU0433182093.SGD","LU1571399168.USD","LU0511384066.AUD","IE00BFXG1179.USD","LU1489326972.SGD","LU0985489474.SGD","BK7067","LU0266013472.USD","LU0006061336.USD","LU0289961442.SGD","BDX","LU1059921491.USD","LU1894683348.USD","BK4504","LU0130518102.USD","LU0878866978.SGD","LU0289739343.SGD","LU1201861165.SGD","LU0162691827.USD","BK4588","LU0648000940.SGD","LU0072461881.USD","BK4585","LU1150488135.SGD","BK4082","LU1150488218.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644774521","title":"BUZZ-Australia's BCAL Diagnostics soars on development of new blood test for breast cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2644774521","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644774521?lang=en_us&edition=fundamental","pubTime":"2026-06-18 13:08","pubTimestamp":1781759280,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's BCAL Diagnostics soars on development of new blood test for breast cancer** Shares of Australia's BCAL Diagnostics BDX.AX gain as much as 133.3% to A$0.140, set for biggest gain since August 2, 2023** Stock hit its highest level since January 16** Biotechnology co develops a blood test, \"BREASTEST\" monitor - a simpler way for women to be evaluated for local recurrence of breast cancer** Co's preliminary findings in women aged 50 years and above show the test identified 20 of 23 confirmed local recurrence cases** Adds, BREASTEST will enter the market as an adjunct to imaging, while it plans to eventually develop it as a standalone surveillance test** 11.5 million shares trade hands vs 30-day average of 145,162 shares** Shares down 12.38% YTD  ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nL4N42Q0CM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDX.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642600342","title":"BofA Adjusts Price Target on Becton, Dickinson and Company to $170 From $177","url":"https://stock-news.laohu8.com/highlight/detail?id=2642600342","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642600342?lang=en_us&edition=fundamental","pubTime":"2026-06-12 20:02","pubTimestamp":1781265722,"startTime":"0","endTime":"0","summary":"Becton, Dickinson and Company (BDX) has an average rating of overweight and mean price target of $173.45, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic re","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0068578508.USD","LU1854104046.USD","LU1894683264.USD","LU0477156797.USD","BDX.AU","LU1854103824.USD","LU0985320562.USD","LU0130103400.USD","LU0433182093.SGD","LU1571399168.USD","LU0511384066.AUD","IE00BFXG1179.USD","LU1489326972.SGD","LU0985489474.SGD","BK7067","LU0266013472.USD","LU0006061336.USD","LU0289961442.SGD","BDX","LU1059921491.USD","LU1894683348.USD","BK4504","LU0130518102.USD","LU0878866978.SGD","LU0289739343.SGD","LU1201861165.SGD","LU0162691827.USD","BK4588","LU0648000940.SGD","LU0072461881.USD","BK4585","LU1150488135.SGD","BK4082","LU1150488218.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640642967","title":"A Look At Becton Dickinson (BDX) Valuation After The Elyra Kidney Stone Care Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2640642967","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640642967?lang=en_us&edition=fundamental","pubTime":"2026-06-02 04:21","pubTimestamp":1780345273,"startTime":"0","endTime":"0","summary":"Why the Elyra launch matters for Becton Dickinson (BDX) shareholders\nBecton Dickinson (BDX) has introduced its Elyra Thulium Fiber Laser System for kidney stone care, rounding out its urologic portfolio and drawing fresh attention to how this product expansion might influence the stock.\nSee our latest analysis for Becton Dickinson.\nAt a share price of US$147.12, Becton Dickinson has seen its share price fall over the past quarter and year to date, while the 1 year total shareholder return...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/a-look-at-becton-dickinson-bdx-valuation-after-the-elyra-kid","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/a-look-at-becton-dickinson-bdx-valuation-after-the-elyra-kid","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1854103824.USD","LU0289739343.SGD","BK4082","LU0006061336.USD","LU1894683348.USD","LU0648000940.SGD","LU1489326972.SGD","LU1854104046.USD","BK4585","LU0072461881.USD","BDX","BDX.AU","LU1150488135.SGD","LU1894683264.USD","IE00BFXG1179.USD","LU0433182093.SGD","LU0511384066.AUD","LU0985320562.USD","LU0266013472.USD","LU0878866978.SGD","LU0985489474.SGD","LU1150488218.USD","LU1201861165.SGD","BK4588","LU0130518102.USD","LU1059921491.USD","SGY","LU0477156797.USD","LU0068578508.USD","BK7067","BK4504","LU0289961442.SGD","LU0130103400.USD","LU0162691827.USD","LU1571399168.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":57,"code":"91000000","status":"200"}]}}